- Home
- ALCO vs AVTX Comparison
ALCO vs AVTX Comparison
Compare ALCO & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALCO
- AVTX
- Stock Information
- Founded
- ALCO 1960
- AVTX 2011
- Country
- ALCO United States
- AVTX United States
- Employees
- ALCO N/A
- AVTX N/A
- Industry
- ALCO
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- ALCO
- AVTX Health Care
- Exchange
- ALCO Nasdaq
- AVTX Nasdaq
- Market Cap
- ALCO 267.7M
- AVTX 248.3M
- IPO Year
- ALCO N/A
- AVTX 2015
- Fundamental
- Price
- ALCO $32.10
- AVTX $18.04
- Analyst Decision
- ALCO
- AVTX Strong Buy
- Analyst Count
- ALCO 0
- AVTX 9
- Target Price
- ALCO N/A
- AVTX $30.14
- AVG Volume (30 Days)
- ALCO 20.8K
- AVTX 396.9K
- Earning Date
- ALCO 11-24-2025
- AVTX 11-06-2025
- Dividend Yield
- ALCO 0.62%
- AVTX N/A
- EPS Growth
- ALCO N/A
- AVTX N/A
- EPS
- ALCO N/A
- AVTX N/A
- Revenue
- ALCO $44,199,000.00
- AVTX $192,000.00
- Revenue This Year
- ALCO N/A
- AVTX N/A
- Revenue Next Year
- ALCO N/A
- AVTX N/A
- P/E Ratio
- ALCO N/A
- AVTX N/A
- Revenue Growth
- ALCO N/A
- AVTX N/A
- 52 Week Low
- ALCO $24.76
- AVTX $3.39
- 52 Week High
- ALCO $35.90
- AVTX $19.41
- Technical
- Relative Strength Index (RSI)
- ALCO 34.85
- AVTX 63.79
- Support Level
- ALCO $32.46
- AVTX $14.01
- Resistance Level
- ALCO $34.02
- AVTX $16.03
- Average True Range (ATR)
- ALCO 0.81
- AVTX 1.46
- MACD
- ALCO -0.18
- AVTX -0.10
- Stochastic Oscillator
- ALCO 0.59
- AVTX 87.28
About ALCO Alico Inc.
Alico Inc is a Florida-based agribusiness and land management company that primarily focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells primarily Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers most of the revenue as the firm's primary operating business unit.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).